Abstracts and Presentations (146)

ISHLT, Virtual, April 2021

Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients: Does Early-Onset Portend a Worse Prognosis?
M. Khoury, J. Conway, J. Gossett, E. Edens, S. Soto, R. Cantor, D. Koehl, A. Barnes, V. Exil, L. Glass, J. Kirklin, W. Zuckerman

Early Report On Covid-19 Infections In Pediatric Heart Transplant Recipients And Candidates
J. Conway, S. Auerbach, M. Richmond, N. Timkovich, E. Pahl, B. Feingold, E. Azeka, W. J. Dreyer, R. Cantor, J. K. Kirklin

Impact Of Race On Listing And Waitlist Mortality In Pediatric Cardiac Transplantation
N. Bansal, A. K. Lal, R. S. Cantor, D. Koehl, J. K. Kirklin, W. J. Ravekes, S. Auerbach, C. Baker-Smith, A. Cabrera, S. Amdani, S. Urschel

Impact of Insurance and Race on Pediatric Heart Transplant Outcomes- An Analysis of the Pediatric Heart Transplant Society (PHTS) Registry
Ashwin K. Lal, MD, Neha Bansal, MD, Ryan S. Cantor, PhD, Devin Koehl, MSDS, Simon Urschel, MD, Alfred Asante-Korang, MD, Waldemar F. Carlo, MD, Jennifer Conway, MD, Natasha Deal, LSCW, James K. Kirklin, MD, Jake A Kleinmahon, MD, Melanie D. Everitt, MD

Aspirin use and cardiac allograft vasculopathy in pediatric heart transplant recipients
Laura D’Addese, R. Cantor, D. Koehl, L. Reardon, R. Ameduri, M. Bock, A. Morrison, S. White, B. Wisotzkey, J. K. Kirklin, J. Godown

Waitlist and post-transplant outcomes for children with myocarditis listed for heart transplantation over three decades: A multi-institutional analysis
Shahnawaz Amdani; Alfred-Asante Korang; Yuk Law; Ryan Cantor; Devin Koehl; James K. Kirklin; Marion Ybarra; Paolo Rusconi; Estela Azeka; Adriana Carolina Prada Ruiz; Kenneth Schowengerdt; Hannah Bostdorff; Anna Joong


AHA, Virtual, November 2020

Optimal Metrics for Assessing Donor-recipient Size Mismatch in Pediatric Heart Transplantation: A PHTS Multi-institutional Analysis)
Shahnawaz Amdani, Othman Aljohani, James K Kirklin, Ryan Cantor, Devin Koehl, Kurt Schumacher, Deipanjan Nandi, Michael Khoury, William Dreyer, Kristen Rose-Felker, Colleen Nasman, Mariska Kemna

Annual Transplant Volume Does Not Affect Center Specific Mortality- A PHTS Database Study
Aecha M Ybarra, Matthew J O’Connor, Seth Hollander, Maria Bano, Michelle Ploutz, Gabrielle Vaughn, Andrea N Lambert, Michael Wallendorf, James K Kirklin, Charles E Canter

Risk Factors for One-year Mortality and Allograft Loss in Pediatric Heart Transplant Patients Using Machine Learning: Analysis of the Pediatric Heart Transplant Society Database
Bethany Wisotzkey, Alfred Asante-Korang, James Kirklin, Ryan Cantor, Devin Koehl,  Byron Jeager, Phil Thrush, Ben Mantell, Melanie Everitt, Molly Brickler, Micheal Kuhn

Impact of VAD Support Duration on Pediatric Heart Transplant Outcomes
Arene Butto, Chad Y Mao, Lydia Wright, Martha Wetzel, Michael Kelleman, Michael P Carboni, Anne I Dipchand, Kenneth R Knecht, Zdenka Reinhardt, Joshua D Sparks, Chet Villa, William T Mahle

Favorable Outcomes for Heart Transplantation in Barth Syndrome as Demonstrated by Multicenter/multiregistry Analysis
Yu Li, Justin Godown, Carolyn Taylor, Anne Dipchand, Brian Feingold

An Ischaemia Time of Greater Than 6 Hours is Associated With Deleterious Outcomes in Pediatric Heart Transplantation
Adam Arshad, Estela Azeka, Ryan Cantor, Devin Koehl, James Kirklin, Jacob Simmonds, Fawwaz Shaw, JonDavid Menteer, William Ravekes, Renata Shih, Jean Ballweg

Circumstances Surrounding End of Life in Pediatric Heart Transplant: A Report From the Pediatric Heart Transplant Society
Melissa Cousino, Sunkyung Yu, Elizabeth Blume, Heather Henderson, Seth Hollander, Sairah Khan, John Parent, and Kurt Schumacher


ISHLT, Virtual, April 2020

Heart Transplant Outcomes in Children with Fontan-Associated Plastic Bronchitis: A Pediatric Heart Transplant Society Analysis
David W. Bearl, MD, MA, Ryan Cantor, PhD, Devin Koehl, MS, Jeffrey G. Gossett, MD, Matthew Bock, MD, Nancy Halnon, MD, Lauren Glass, MD, Vernat Exil, MD, MBA, Courtney Musselwhite, RN, James Kirklin, MD, Justin Godown, MD, Chitra Ravishankar, MD

Obesity Leads to Increased Mortality in Pediatric Heart Transplant Recipients – A Pediatric Heart Transplant Society Study
Carmel Bogle, MD; Ryan Cantor, PhD; Devin Koehl; Jillien Lochridge, CPNP; James Kirklin, MD; Aliessa Barnes, MD, Gonzalo Wallis, MD; Shahnawaz Amdani, MD; Rebecca Ameduri, MD; Elfriede Pahl, MD; Kathleen Simpson, MD; Elizabeth D. Blume, MD


ACC, March 2020

Effects of dyslipidemia on CAV and graft loss in pediatric heart transplant recipients: A PHTS Multi-institutional analysis
Carmel Bogle, MD; Ryan Cantor, PhD; Devin Koehl; Jillien Lochridge, CPNP; James Kirklin, MD; Aliessa Barnes, MD, Gonzalo Wallis, MD; Shahnawaz Amdani, MD; Rebecca Ameduri, MD; Elfriede Pahl, MD; Kathleen E. Simpson, MD; Elizabeth D. Blume, MD


AHA, Philadelphia, Pennsylvania, November 2019

Prolonged Hospital Length Of Stay After Pediatric Heart Transplantation And Its Impact On Outcomes: A PHTS Database Analysis
Dipankar Gupta, Ryan Cantor, Devin Koehl, Neha Bansal, Chesney Castleberry, Allison Kimbro, Stephen Pophal, Kenneth O Schowengerdt Jr, Alfred Asante-Korang, Paolo Rusconi, James K Kirklin, David L Sutcliffe

The Fontan Immunophenotype and Post-Transplant Outcomes in Children: A Multi-Institutional Study
Benjamin S. Mantell, Estela Azeka, Ryan S. Cantor, Waldemar F. Carlo, Maryanne Chrisant, John C. Dykes, Timothy M. Hoffman, James K. Kirklin, Devin Koehl, Thomas J. L’Ecuyer, Jennie M. McAllister, Adriana C. Prada-Ruiz, Marc E. Richmond


ISHLT 2019, Orlando, Florida

Retransplantation: An underutilized resource or only for a select few?
Mari Vazquez Alvarez, Elizabeth Pruitt, Deipanjan Nandi, Mariska Kemna, Simon Urschel, Shawn West, Kim Lin, Heang Lim, Tina Allain-Rooney, Anne Dipchand

ABO Incompatible Listing in Early Childhood Results in Earlier Transplantation and Equal Post-Transplant Survival Despite Predominant Use in Sicker Patients
Simon Urschel, Marie McCoy, Zdenka Reinhardt, Anne Dipchand, Ryan Cantor, Devin Koehl, James Kirklin, Jean Ballweg, Kirk Kanter, Warren Zuckerman, Joshua Sparks, Wally Carlo

MELD-XI Score Predicts Post-Heart Transplant Survival in Fontan Patients: A PHTS Analysis
Shahnawaz Amdani, Katie Simpson, Phil Thrush, Renata Shih, Jacob Simmonds, Ken Knecht, Douglas Mogul, Kathleen Hurley, Devin Koehl, David Naftel, James Kirklin, Kevin Daly

ABO Incompatible Heart Transplantation in Young Children: Less Rejection and Infection
Simon Urschel, Marie McCoy, Ryan Cantor, Devin Koehl, Warren Zuckerman, Anne Dipchand, Zdenka


AHA, Chicago, Illinois, November 2018

Educational and Learning Morbidity in Pediatric Heart Transplant Recipients: A Pediatric Heart Transplant Society Study
Micah S Brosbe, Lydia Wright, Elizabeth Pruitt, William J Dreyer, Sonya Kirmani, Margaret Knight, Stephanie Nakano, Steven J Kindel, Thomas D Ryan, James K Kirklin, Shriprasad R Deshpande


ISHLT, Nice, France, April 2018

Practice variation in the diagnosis of acute rejection among pediatric heart transplant centers: An analysis of the Pediatric Heart Transplant Study (PHTS) Database
J. Godown, E. Pruitt, J. Vo, D. Dodd, I. Lytrivi, G. Boyle, D. Sutcliffe, J. Kleinmahon, R. Shih, S. Urschel, B. Das, W. Carlo, W. Zuckerman, S. West, M. McCulloch, M. Zinn, K. Simpson, S. J. Kindel, J. Szmuszkovicz, M. Chrisant, S. Auerbach, M. Carboni, D. Hsu

Failure to Improve Renal Function Following VAD Placement Predicts Renal Injury and Chronic Kidney Disease Following Cardiac Transplant
S. Hollander, E. Pruitt, S. Sutherland, R. Cantor, J. Kirklin, W. Ravekes, R. Ameduri, M. Chrisant, T. Hoffman, I. Lytrivi, J. Conway

The Effect of Infectious Complications During Ventricular Assist Device Use on Outcomes of Pediatric Heart Transplantation
S. Auerbach, E. Pruitt, T. Bradford, M. Bock, E. Skipper, R. Cantor, D. Koehl, K. Butler, J. Alejos, E. Edens, J. Kirklin

Worse Survival after Heart Transplantation in Children with Heterotaxy Syndrome
A. Khan, E. Pahl, E. Pruitt, J. Kirklin, E. Azeka, P. Rusconi, S. Guan, A. Barnes, S. Blendsdorf, M. Everitt

Practice Variation in Detection of Coronary Allograft Vasculopathy (CAV) in Children: A Pediatric Heart Transplant Study
E. Pahl, D. Nandi, J. Vo, K. Schumacher, M. Fenton, R. Singh, K. Lin, J. Conway, E. Pruitt, S. Dahl, J. Lamour, J. Kirklin, C. Chin

Earlier Cardiac Allograft Vasculopathy and Graft Failure in Pediatric Heart Transplant Recipients after Rejection with Severe Hemodynamic Compromise
J. Kleinmahon, J. Gralla, S. Auerbach, G. Wallis, K. Ramakrishnan, R. Singh, R. Caldwell, R. Kirk, A. Savage, H. Henderson, M. Everitt


AHA, Anaheim, CA, November 2017

Are routine surveillance invasive hemodynamics obtained post-transplant useful in pediatric heart transplant recipients?
Arbon KS, Law YM, Kirklin JK, Pruitt E, Showengerdt KO, Hoffman TM, L’Ecuyer TJ, Kindel SJ.

Outcomes of Infants with Pulmonary Atresia with Intact Ventricular Septum Listed for Cardiac Transplantation: A Multi-Institutional Study
Joong A, Pruitt E, Zuckerman WA, Blackston JW, Ameduri RK, Alejos JC, Boyle GJ, Rothkopf AC, Kirklin JK, Garjarski RJ.


ISHLT, San Diego, CA, April 2017

Association of Insurance Coverage on the Development of Coronary Allograft Vasculopathy after Pediatric Heart Transplant
Pruitt E, Urschel S, Everitt MD, Kirklin JK, Naftel DC

HLA Eplet Mismatching Is Associated with Increased Risk of Graft Loss in Pediatric Heart Transplant Recipients
Albers E, Kronmal R, Jorgensen N, Kemna M, Hong B, Friedland-Little J, Law Y, and Warner P.

Mechanical Circulatory Support (MCS) in Infants with Congenital Heart Disease listed for heart transplant – A PHTS Multicenter Experience
Conway J, Pruitt E, Spicer R, Gupta D, McCulloch M, Asante-Korang A, Eulrich DT, Kirklin JK, Pahl E

Hemodynamics of the Pediatric Failing Fontan
Dykes JC, McElhinney DB, Bernstein D, Chen S, Chrisant MR, Daly KP, Ameduri RK, Knecht K, Richmond ME, Lin K, Urschel S, Simmonds J, Simpson KE, Almond CS, Chen S

The long-terms outcomes of patients supported with the Berlin Heart EXCOR as a bridge to transplantation: A multi-institutional study
Jeewa A, Imamura M, Canter C, Niebler R, VanderPluym C, Rosenthal D, Kirklin JK, Tresler M, McMullan M, Morell V, Turrentine M, Ameduri R, Nguyen K, Kanter K, Conway J, Gajarski R, Fraser Jr CD

Post-Transplant Outcomes in Pediatric VAD Patients: A Pedimacs-PHTS Linkage Study
Sutcliffe DL, Pruitt E, Cantor RS, Godown J, Lane J, Turrentine MW, Law SP, Lantz JL, Naftel DC, Kirklin JK, Bernstein D, Blume ED


AHA, New Orleans, Louisiana, November 2016

Pediatric Heart Transplantation in Pre-Sensitized Recipients: A Current Perspective
Das B, Pruitt E, Molina K, Ravekes W, Auerbach S, Savage A, Knox L, Kirklin JK, Naftel DC, Hsu D

New-onset Diabetes After Pediatric Heart Transplantation
Sparks JD, Pruitt EP, Kirklin JK, Brown T, Carboni MP, Dreyer WJ, Kindel S, Ryan TD, Morrow R


ISHLT, Washington DC, April 2016

Bacterial Infections Following Pediatric Heart Transplantation: Epidemiology, Risk Factors, and Outcomes
Rostad C, Wehrheim K, Kirklin JK, Pruitt E, Berkowitz K, Hoffman T, L’Ecuyer T, Mahle W, Scheel J

Cancer Recurrence and Mortality after Pediatric Heart Transplantation for Anthracycline Cardiomyopathy
Bock M, Kirklin JK, Pruitt E, Pahl E, Rusconi P, Boyle G, Parent J, Bernstein D

Impact of Induction Therapy Type in High and Low Risk Pediatric Patients after Heart Transplant: Analysis of the PHTS Database
Castleberry C, Ameduri R, Schowengerdt K, Edens E, Hagin N, Kirklin JK, Pruitt E, Urschel S

Mechanical Support for Primary Graft Failure and Early Rejection in Pediatric Heart Transplantation
Simmonds J, Kirklin JK, Pruitt E, Gupta D, Bohannan S, Zangwill S, Dodd D, Addonizio L

Mechanical Circulatory Support as a Bridge to Transplantation in Children with Single Ventricle Physiology: A Multicenter Study
Das B, Kirklin JK, Pruitt E, Daneman S, Lin K, Hong B, Chrisant M, Canter C

Development and Validation of a Major Adverse Transplant Event (MATE) Score to Predict Graft Failure in Pediatric Heart Transplantation
Almond C, Hoen H, Rossano JW, Castleberry C, Auerbach S, Yang L, Lal AK, Everitt M, Pahl E, Fenton M, Hollander S, McElhinney DB, Pruitt E, Rosenthal D, Daly K, Desai M

The Impact of Age on the Incidence and Prevalence of Moderate to Severe Cellular Rejection Detected by Routine Surveillance Biopsy in Pediatric Heart Transplantation
Zinn M, Simpson K, Wallendorf M, Osborne A, Kirklin JK, and Canter C

Impact of Routine Surveillance Biopsy Intensity on the Diagnosis of Moderate to Severe Cellular Rejection and Survival After Pediatric Heart Transplantation
Zinn M, Simpson K, Wallendorf M, Osborne A, Kirklin JK, and Canter C

Hemodynamic Findings Associated with End-Organ Dysfunction in Children with End-Stage Heart Failure
Chen S, McElhinney DB, Dykes JC, Rosenthal DN, Hollander SA, Maeda K, Jensen K, Yarlagadda VV, Ford M, Price J, Pruitt E, Almond CS

Relationship between Hemodynamic Variables and NYHA/Ross Functional Capacity in Children with Advanced Heart Failure
Dykes JC, Chen S, Lin A, Rosenthal D, Maeda K, McElhinney DB, Pruitt E, Price J, Almond CS


MWPCS, Peora, IL, September 2015

A Multi-Institutional Evaluation of Antibody-Mediated Rejection Utilizing the PHTS Database: Incidence, Therapies, and Outcomes
Thrush PT, Pahl E, Naftel DC, Pruitt E, Everitt MD, Missler H, Zangwill SD, Burch M, Hoffman TM, Butts RJ, Mahle WT


AATS, Seattle, WA, April 2015

Outcomes of Heart Transplantation in Children with Hypoplastic Left Heart Syndrome Previously Palliated with the Norwood Procedure
Alsoufi B, Mahle W, Manlihiot C, Deshpande S, Kogon B, McCrindle B, Kanter K


ISHLT, Nice, France, April 2015

Hemodynamic Profiles in Children with End-Stage Heart Failure: Analysis of Data from the Pediatric Heart Transplant Study Group
Chen S, Gajarski R, Lin A, May LJ, Rosenthal DN, Everitt ME, McElhinney DB, Shin AY, Kaufman E, Pruitt E, Almond CS

Lymphoproliferative Disorders Late After Pediatric Heart Transplantation: A Multicenter Analysis
West SC, Friedland-Little J, Schowengerdt Jr., K, Naftel DC, Pruitt E, Smith KS, Urschel S, Kirklin JK, Michaels M, Feingold BD

A Multi-Institutional Evaluation of Antibody-Mediated Rejection Utilizing the PHTS Database: Prevalence, Therapeutic Approaches, and Outcomes
Thrush PT, Pahl E, Naftel DC, Pruitt E, Everitt MD, Missler H, Zangwill SD, Burch M, Hoffman TM, Butts RJ, Mahle WT

Impact of Initial Norwood Shunt Type on Young HLHS Patients Listed for Heart Transplant: A Multi-Institutional Study
Carlo WF, West S, McCulloch M, Naftel DC, Pruitt E, Kirklin JK, Hubbard M, Molina K, Gajarski, R

Early Statin Therapy Is NOT Associated with Improved Outcomes After Heart Transplantation in Children
Greenway SC, Butts R, Naftel DC, Pruitt E, Kirklin JK, Urschel S, Knecht K, Law Y


AHA, Chicago, November 2014

Survival of Fontan Patients after Heart Transplant; Has Survival Improved in the Current Era?
Simpson KE, Kirklin JK, Naftel DC, Pruitt E, Singh R, Edens RE, Barnes AP, Canter CE


ISHLT, San Diego, April 2014

Fontan-associated Protein Losing Enteropathy and Heart Transplant: A Pediatric Heart Transplant Study Analysis
Schumacher K, Zamberlan M, Naftel D, Pruitt E, Carboni M, Guleserian K, Dodd D, Gossett J, Lamour J, Pophal S, Gajarski R


AHA, Dallas, November 2013

Use of Sirolimus in Pediatric Heart Transplant Patients: A Multi-institutional Study from the Pediatric Heart Transplant Study Group
Rossano J, Jefferies J, Pahl E, Naftel D, Pruitt E, Lupton E, Dreyer W, Chinnock R, Boyle G, Mahle W


ISHLT, Montreal, April 2013

Elevated Pre-Transplant Pulmonary Vascular Resistance Is Not Associated with Mortality in Children without Congenital Heart Disease: A Multi-Center Study
Richmond M, Law Y, Das B, Everitt M, Kukreja M, Naftel D, Kemna M, Henderson H, Beddows K, Fricker J, and Mahle W

Maintenance Steroid Use and Outcomes of Pediatric Heart Transplantation: A Propensity Matched Analysis of the Pediatric Heart Transplant Study (PHTS) Database
Auerbach S, Kukreja M, Gilbert D, Bastardi H, Feingold B, Knecht K, Kaufman B, Brown R, and Miyamoto S


AHA, Los Angeles, November 2012

Ventricular Assist Device (VAD) Support As A Bridge To Pediatric Heart Transplantation: A Practice In Rapid Evolution
Dipchand A, Naftel D, Tresler M, Blume E, Kirk R, Morrow W, Auerbach S, Richmond M, Rosenthal D, Kirklin J


ISHLT, Prague, April 2012

Predicting 1-year survival in pediatric heart transplant candidates with cardiomyopathy: an analysis of the PHTS database
Schumacher K, Kirk R, Almond C, Singh T, Spicer R, Hoffman T, Hsu D, Canter C, Naftel D, Tresler M, Zamberlan M, Gajarski R

Predicting 1-year survival in pediatric heart transplant candidates with Congenital Heart Disease: an analysis of the PHTS database
Schumacher K, Kirk R, Almond C, Singh T, Spicer R, Hoffman T, Hsu D, Canter C, Naftel D, Tresler M, Zamberlan M, Gajarski R

Is adolescence an independent risk factor for rejection in pediatric heart transplantation, independent of age at listing?
VanderPluym C, Bastardi H, Scheel J, Kaufman B, Fricker J, Schneider D, Naftel D, Tresler M, Das B, Gandy J, Blume B

Outcomes of Cardiac Transplantation in Single Ventricle Patients with Plastic Bronchitis—a Multi-Center Report
Gossett J, Almond C, Kirk R, Zangwill S, Richmond M, Kantor P, Tresler M, Lenderman S, Naftel D, Matthews K, Pahl E

Cardiac Allograft Vasculopathy (CAV) in Children: an 18 year Pediatric Heart Transplant Study (PHTS) Analysis in 3120 patients
Kindel S, Chin C, Law Y, Burch M, Kirklin J, Naftel D, Carboni M, Arens A, Atz A, Dreyer J, Pahl E


AHA, Orlando, November 2011

Heart transplant after failed single ventricle palliation in young infants carries excess mortality risk: A multi institutional study
Everitt M, Boyle G, Schechtman K, Zheng J, Kaza A, Bullock E, Dipchand A, Naftel D, Kirklin J, Canter C

ECMO as a Bridge to Pediatric Heart Transplantation: Impact on Post-Listing and Post-Transplantation Outcomes
Dipchand A, Mahle W, Tresler M, Naftel D, Kirklin J, Webber S

Outcome of Fetal Listing for Heart Transplantation
Conway J, Chrisant M, West L, Alejos J, Das B, Gilbert D, Lamour J, Ameduri R, Tresler M, Naftel D, Miyamoto S


IPTA, Montreal, June 2011

The role of age, EBV status and ERA on PTLD incidence in pediatric heart transplant recipients: a 16 year multi-institutional retrospective review (submitted)
Chinnock R, Webber S, Dipchand A, Brown R, George J

Outcomes after percutaneous coronary artery revascularization procedures for allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional experience
Jeewa A, Chin C, Pahl E, Atz A, Carboni M, Tresler M, Naftel D, Rodriguez R, Allen-Rooney T, Dipchand A

Donor Characteristics and Impact on Outcomes in Pediatric Heart Transplant Recipients
Conway J, Chin C, Kemma M, Burch M, Barnes A, Tresler M, Scheel J, Naftel D, Beddow K, Allain-Rooney T, Dipchand A

Hypoalbuminemia and Poor Growth Predict Worse Outcomes Post Heart Transplant in Children
Castleberry C, White-Williams C, Naftel D, Tresler M, Miyamoto S, Ainley K, Murphy D, Spicer R, Palm G, Bannister L, Schowengerdt K, Gilmore L, Kaufman B, Zangwill S


ISHLT, San Diego, April 2011

Outcomes after percutaneous coronary artery revascularization procedures for allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional experience
Jeewa A, Chin C, Pahl E, Atz A, Carboni M, Tresler M, Naftel D, Rodriguez R, Allen-Rooney T, Dipchand A

Hypoalbuminemia and Poor Growth Predict Worse Outcomes Post Heart Transplant in Children
Castleberry C, White-Williams C, Naftel D, Tresler M, Miyamoto S, Ainley K, Murphy D, Spicer R, Palm G, Bannister L, Schowengerdt K, Gilmore L, Kaufman B, Zangwill S

Donor Characteristics and Impact on Outcomes in Pediatric Heart Transplant Recipients
Conway J, Chin C, Kemma M, Burch M, Barnes A, Tresler M, Scheel J, Naftel D, Beddow K, Allain-Rooney T, Dipchand A

ABO-incompatible heart transplantation in infants: Analysis of the Pediatric Heart Transplant Study (PHTS) database
Henderson H, Canter C, Mahle W, Dipchand A, LaPorte K, Schechtman K, Zheng J, Asante-Korang A, Singh R, Kanter K

A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients
George J, Chinnock R, Brown R, Dipchand A, Webber S


AHA, Chicago, November 2010

Risks Associated with Allosensitization in Pediatric Heart Transplantation
Mahle W, Naftel D, Foushee M, Rusconi P, Edens E, George J, Shaddy R

Has Late Rejection Decreased in Pediatric Heart Transplantation in the Current Era? A Multi-institutional Study
Ameduri R, Zheng J, Schechtman K, Hoffman T, Gajarski R, Chinnock R, Naftel D, Kirklin J, Dipchand A, Canter C

Outcomes of Pneumocystis jiroveci pneumonia infections in Pediatric Heart Transplant Recipients
Edens R, Naftel D, Dipchand A, Rusconi P, Boyle G, Zaoutis T, and the Pediatric Heart Transplant Study Group


ISHLT, Chicago, April 2010

Use of Induction Agents and Incidence of Infection and Malignancy Following Pediatric Heart Transplantation
Gajarski R, Blume E, Schechtman K, Zheng J, West L, Urschel, Miyamoto S, Altamirano, Naftel D, Kirklin J, Zamberlan M, Canter C

Comparison of Risk Factors and Outcomes for Pediatric Patients Listed for Heart Transplantation after Bidirectional Glenn and after Fontan: A Multi-Institutional Study
Kovach J, Blume E, Naftel D, Pearce B, Foushee M, Edens E, Shuhaiber J, Fynn-Thompson F, Kirklin J, Zangwill S

Risk Factors for Renal Dysfunction in Pediatric Heart Transplantation: A Multi-institutional Study
Feingold B , Zheng J, Law Y, Morrow R, Hoffman T, Schechtman K, Canter C

Minimizing Infection and Rejection Death: Clues Acquired from 17 Years of Multi-institutional Cardiac Transplantation Data
George J, Taylor D, Blume E, Kirklin J, Naftel D, Brown R, Dipchand A, Tallaj

The Impact of HLA-G Polymorphism on Acute Rejection in Pediatric Heart Transplantation (Joint Project with SCCOR)
Zeevi A, Brooks, Girnita, Ferrell, Chinnock R, Cannter C, Addonizio L, Berstein, Kirklin J, Naftel Webber S


AHA, Orlando, November 2009

Rejection with Hemodynamic Compromise in the Current Era of Pediatric Heart Transplantation: a Multi-institutional Study
Everitt M, Cantor C, Schechtman K, Zhang J, Pahl E, Bullock E, Ringewald J, L’Ecuyer T, Naftel D, Kirklin J, Blume E

When Pediatric Heart Transplant Recipients Become Adults- Does Transition to Adult Care Affect Outcomes?
McBride M, Foushee M, Brown R, Taylor D, Naftel D, Ewald G, Trehan I, Kirklin J, Canter C


ISHLT, Paris, France, April 2009

Heart Transplantation Survival in Infants with Congenital Heart Disease with and without Prior Surgery: A Multi-Institutional Study
Boyle G, Guleserian K, Zheng J, Schechtman K, Everitt M, Nasman C, Canter C

Decline in Rejection in the First Year after Pediatric Cardiac Transplantation: A Multi-Institutional Study
Gossett J, Canter C, Zheng J, Schechtman K, Blume E, Rodgers S, Naftel D, Kirklin J, Scheel J, Fricker F, Kantor P, Pahl E, and the PHTS Investigators

Outcomes Following Listing for Primary Transplantation for Infants with Unoperated Non-Hypoplastic Left Heart Syndrome (Non-HLHS) Congenital Heart Disease: A Multi-Institutional Study
Guleserian K, Schechtman K, Zheng J, Edens R, Jacobs J, Mahle W, Emerson S, Blume E, Canter C, and the PHTS Investigators

Does Cytomegalovirus Serology Impact Outcome Following Pediatric Heart Transplantation?
Mahle W, Alejos J, Foushee M, Naftel D, Rao J, Caldwell R, Uzark K, Berg A, Kanter K, and the Pediatric Heart Transplant Study

Association of Socioeconomic Status with Graft Failure in Pediatric Heart Transplant Recipients
Singh T, Naftel D, Addonizio L, Mahle W, Foushee M, Zangwill S, Blume E, Kirklin J, and Chinnock R


ACC, Orlando, March 2009

Sudden Death After Pediatric Heart Transplantation: Analysis of Data From the Pediatric Heart Transplant Study (PHTS)
Almond C, Chakravarti S, Myers S, Foushee M, Dillis S, Pahl E, Schowengerdt K, Alejos J, Naftel D


AHA, New Orleans, Louisiana, November 2008

The Impact of Heart Failure Severity at Time of Listing for Cardiac Transplantation on Short and Long Term Stability with Pediatric Cardiomyopathy.
Larsen R, Naftel D, Rosenthal D, Blume E, Mahle W, Yung D, Morrow R, Orav J, Wilkinson J, Towbin J, Lipshultz S, Canter C.


ISHLT, Boston, Massachusetts, April 2008

The Impact of High-Risk Criteria on Mortality Following Heart Transplantation in Children: A Multi-Institutional Study.
Davies R, Chen J, Naftel D, Boyle G, Zangwill S, Gajarski R, Robinson B, Kirk R, Hsu D, Blume E.

Serum Creatinine is a Limited Indicator of Renal Function in Pediatric Heart Transplantation
Feingold B, Schechtman K, Law Y, Spicer R, Hoffman T, Darragh R, Asante-Korang A, Finney H, Zheng J, Hmiel P, Canter C.

Outcomes of Pediatric Patients with Hypertrophic Cardiomyopathy Listed for Transplant
Garjaski R, Naftel D, Pahl E, Alejos J, Pearce B, Kirklin J, Zamberlan M, Dipchand A.

Dilated Cardiomyopathy and Listing for Heart Transplantation: A Multi-Institutional Study
Kirk R, Naftel D, Hoffman T, Almond C, Boyle G, Caldwell R, Kirklin J, Flett J, Dipchand A.

Pediatric Heart Transplantation: 14 Years of Improving Results Illustrated by Patient Specific Predictions.
Naftel D, Kirklin J, Hsu D, Blume E, Webber S, Morrow W, Canter C.

Outcomes of Children with Restrictive Cardiomyopathy Listed for Heart Transplant: A Multi-Institutional Study
Zangwill S, Naftel D, L’Ecuyer T, Rosenthal D, Robinson B, Kirklin J, Stendhal G, Dipchand A.


AHA, Orlando, Florida, November 2007

Outcomes of Pneumocystis jiroveci pneumonia infections in Pediatric Heart Transplant Recipients
Edens R, Naftel D, Dipchand A, Rusconi P, Boyle G, Zaoutis T, and the Pediatric Heart Transplant Study Group.
The Journal of Heart and Lung Transplantion, 2008.


ISHLT, San Francisco, California, April 2007

Outcomes of Pneumocystis jiroveci pneumonia infections in Pediatric Heart Transplant Recipients
Edens R, Naftel D, Dipchand A, Rusconi P, Boyle G, Zaoutis T.


ISHLT, Madrid, Spain, April 2006

Epidemiology, Risk Factors, and Outcomes of Fungal Infections in Pediatric Heart Transplant Recipients
Zaoutis T, Naftel D, Chrisant M, Kaufman B, Pearce B, Spicer R, Harris T, Webber S, and the Pediatric Heart Transplant Study.

Cardiac Retransplantation in Pediatrics: A Multi-Institutional Study
Chin C, Naftel D, Pahl E, Shankel T, Clark M, Gamberg P, Kirklin J, Webber S and the Pediatric Heart Transplant Study.

To Vaccinate or Not to Vaccinate: Results of the Pediatric Heart Transplant Study (PHTS) Vaccination Study
White-Williams C, Naftel D, Webber S, Michaels M, Berg A, Bullock E, Dubois J, Rodgers S, and the Pediatric Heart Transplant Study Coordinator Group.

Improved Rejection Free Survival with Adjunctive Mycophenolate vs Azathioprine in Pediatric Heart Transplant Recipients
Morrow W, Naftel D, Edens E, Lamour J, Canter C, Parker J, Ainley K, Kajevska I, Myers S, Kirklin J, and the Pediatric Heart Transplant Study.


ISHLT, Philadelphia, PA, April 2005

Outcome of Children Bridged to Transplant with Ventricular Assist Devices: A Multi-Institutional Study
Blume E, Naftel D, Bastardi H, Duncan B, Kirklin J, Webber S, and the Pediatric Heart Transplant Study.

Sudden Cardiac Death Prior to Pediatric Heart Transplantation: Would Implantable Defibrillators Improve Outcome?
Rhee E, Canter C, Basile S, Naftel D, and the Pediatric Heart Transplant Study.

Should Status II Patients Be Removed From the Pediatric Heart Transplant Waiting List: A Multi-Institutional Study
Kirklin J, Naftel D, Pearce F, White-Williams C, Caldwell R, Bartlett H, Rusconi P, Robinson B and the Pediatric Heart Transplant Study.

Adjunctive Mycophenolate vs. Azathioprine for Prevention of Rejection in Pediatric Heart Transplant Recipients
Morrow W, Parker J, Naftel D, Mital S, Canter C, Drummon-Webb J, Kajevska I, Bryant J, Kirklin J, and the Pediatric Heart Transplant Study.

Have Changes in UNOS Status System Improved Allocation in Pediatric Heart Recipients?
Addonizio L, Zangwill S, Rosenthal D, Naftel D, Korsin R, Hsu D, Kirklin J, and the Pediatric Heart Transplant Study.


ACC, Orlando, FL, March 2005

The Effect of Age, Diagnosis, and Previous Surgery in 488 Children and Adults Who Undergo Heart Transplantation for Congenital Heart Disease
Lamour J, Kanter, K, Naftel D, Chrisant M, Morrow R, Clemson B, Kirklin J, the Pediatric Heart Transplant Study and the Cardiac Transplant Research Database.


ISHLT, San Francisco, CA, April 2004

Outcome of Listing for Cardiac Transplantation for Failed Fontan: A Follow-up Multi-Institutional Study
Bernstein D, Naftel D, Chin C, Addonizio L, Gamberg P, Hsu D, Blume E, Canter C, Morrow W, Kirklin J, and the Pediatric Heart Transplant Study Group.

Panel-Reactive Antibody Cross-Reactivity and Outcomes in the Pediatric Heart Transplant Study Group
Mahle W, Naftel D, Edens E, Rusconi P, Shaddy R, and the Pediatric Heart Transplant Study Group.

Cytomegalovirus (CMV) Prophylaxis and Infection in Pediatric Heart Transplant Recipients
Kanter K, Naftel D, Pahl E, Canter C, Webber S, Vincent R, Kirklin J, Morrow W and the Pediatric Heart Transplant Study Group.

Late Outcomes After Heart Transplantation in Adults with Congenital Heart Disease: A Multi-Institutional Analysis
Clemson B, Kirklin J, Canter C, Naftel D, Young J, Hill J, Rodeheffer R, Radovancevic B, Faulkner S, the Pediatric Heart Transplant Study and the Cardiac Transplant Research Database.


International Pediatric Transplant Association, Rio de Janeiro, Brazil, April 2003

Role of Early T-Cell Depletion with Thymoglobulin in Pediatric Heart Recipients. The Pediatric Heart Transplant Study (PHTS)
Blume E, Boucek R, Naftel D, Pietra B, Kirklin J, Canter C and the Pediatric Heart Transplant Study Group.

Lessons Learned from the Pediatric Heart Transplant Study Group
Hsu, D, Naftel D, Webber S, Morrow W, Canter C, Chinnock R, Clark M, Kirklin J. Congenital Heart Disease 2006; 1: 54-62.


AHA, Chicago, IL, November 2002

Post-Transplant Lymphoproliferative Disorders: Experience with 56 Cases at 19 Pediatric Heart Transplant Centers
Webber S, Bowman P, Naftel D, Fricker F, Blume E, Addonizio L, Kirklin J, Canter C and the Pediatric Heart Transplant Study Group.

The Incidence and Impact of Transplant Coronary Artery Disease in Pediatric Recipients: A 9 Year Multi-Institutional Study
Pahl E, Naftel D, Kuhn M, Shaddy R, Morrow W, Kirklin J, and the Pediatric Heart Transplant Study Group.


ISHLT, Washington, D.C., April 2002

Linear and somatic Growth Following Pediatric Heart Transplantation
Ibrahim J, Canter C, Chinnock R, Kirklin J, Naftel D, Basile S, West L, and the Pediatric Heart Transplant Study Group.

Hyperlipidemia in Children After Cardiac Transplantation
Singh T, Morrow W, Naftel D, Dupuis J, Spicer R, Schowengerdt K, Ring W, and the Pediatric Heart Transplant Study Group.


ISHLT, Vancouver, Canada, April 2001

Interaction of Volume and Era on Survival of Children Listed For Cardiac Transplantation
Balfour I, Naftel D, Fricker J, Friedman B, Frazier E, Shaddy R, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.

Death After Cardiac Transplantation in Low Birth Weight Neonates
Chinnock R, Naftel D, Singh T, Canter C, Pietra B, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.


International Transplant Nurses Society, Las Vegas, Nevada, September 2000

Pediatric Outcomes: Outcomes of the Pediatric Heart Transplant Study
White-Williams C, Morrow W, and the Pediatric Heart Transplant Study Group.


ISHLT, Osaka, Japan, April 2000

Graft Failure After Heart Transplantation in Children: A Six Year Multi-Center Experience
Morrow W, Naftel D, Caldwell, R, Harrell J, Ainley K, Kirklin J, and the Pediatric Heart Transplant Study Group.

Risk Factors For Recurrent Rejection in Pediatric Heart Transplantation: A Multicenter Experience
Chin C, Naftel D, Singh T, Blume E, Luikart H, Bernstein D, Morrow W, and the Pediatric Heart Transplant Study Group.


AHA, Atlanta, November 1999

Fate of Infants with Hypoplastic left Heart Syndrome Listed for Cardiac Transplant: A Multi-center Study
Kichuk-Chrisant M, Naftel D, Hsu D, Drummond J, Chinnock R, Canter C, Boucek M, Boucek R, Hallowell S, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.


ISHLT, San Francisco, April 1999

Death after Transplantation in Children: Who Dies When and Why?
Frazier E, Naftel D, Canter C, Boucek M, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.

Outcome of Listing for Cardiac Transplantation for Failed Fontan: A Multi-institutional Study
Bernstein D, Naftel D, Hsu D, Addonizio L, Blume E, Gamberg P, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.

Late Rejection Greater Than 1 Year After Pediatric Heart Transplantation: An Ominous Finding
Webber S, Naftel D, Parker J, Mulla N, Balfour I, Cipriani L, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.


ISHLT, Chicago, April 1998

Death after Rejection with Severe hemodynamic Compromise in Pediatric Recipient
Pahl E, Naftel D, Frazier EA, Kirklin J, Morrow WR, and the Pediatric Heart Transplant Study Group.

Preventing Cytomegalovirus Infection (CMV) in Pediatric Heart Transplant Recipients: Does Prophylaxis Work?
Kanter K, Naftel D, Pahl E, Canter C, Webber S, Frazier E, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.


ISHLT, London, April 1997

Induction Immunotherapy in Pediatric Heart Transplant Recipients: A Multi-Institution Evaluation
Boucek R, Naftel D, Boucek M, Morrow R, Chinnock R, Shaddy R, Kirklin J, Pahl E, and the Pediatric Heart Transplant Study Group.


The Third Loma Linda International Conference on Pediatric Heart and Lung Transplantation, January 1997

Outcomes Analysis: The Pediatric Heart Transplant Study Group (PHTS)
Kirklin J, Morrow W, Addonizio L, Canter C, Shaddy R, and the Pediatric Heart Transplant Study Group.


ACC, Orlando, March 1996

Survival and Risk Factors for Death after Cardiac Transplantation in Infants: A Multi-institutional Study
Canter C, Naftel D, Caldwell R, Chinnock R, Pahl E, Frazier E, Kirklin J, Boucek M, Morrow R, and the Pediatric Heart Transplant Study Group.


ISHLT, New York, 1996

Infection after Pediatric Heart Transplantation: A Multi-institutional, Multivariable Analysis
Schowengerdt K, Naftel D, Seib P, Pearce B, Addonizio L, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.

Allograft Rejection Following Cardiac Transplantation in Infants and Children: A Multi-institutional Study
Rotondo K, Naftel D, Boucek R, Canter C, McGiffin D, Pahl E, Chinnock R, Morrow R, Kirklin J, and the Pediatric Heart Transplant Study Group.


AHA, Anaheim, November 1995

Outcome of Cardiac Transplantation in Children: Survival in a Contemporary Multi-institutional Experience
Shaddy R, Naftel D, Gerard B, McGiffin D, Towbin J, Ring S, Pearce B, Addonizio L, Kirklin J, Morrow W, and the Pediatric Heart Transplant Study Group.


ISHLT, San Francisco 1995

Predicting Outcome Following Listing for Cardiac Transplantation in Children: Comparison of Kaplan-Meier and Parametric Competing Risk Analysis
McGiffin D, Naftel D, Kirklin J, Towbin J, Shaddy R, Alejos J, Rossi A, and the Pediatric Heart Transplant Study Group.

Outcome of Listing for Cardiac Transplantation in Infants (age <6mos): Predictors of Death & Interval to Transplant
Morrow R, Naftel D, Chinnock R, Canter C, Boucek M, Zales V, McGiffin D, Kirklin J, and the Pediatric Heart Transplant Study Group.

Risk Factors for Pretransplant Outcome in Children Listed for Cardiac Transplantation: A Multi-institutional Study
Addonizio L, Naftel D, Fricker J, Morrow W, Kirklin J, McGiffin D, Dodd D, Berstein D, and the Pediatric Heart Transplant Study Group.